SHEREE MONTOYA: Open Payments
NPI 1871079384 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 31 payments from 7 companies in 2025. Trend: 2023 $653 · 2024 $537 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $264 |
| Lilly USA, LLC | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Exact Sciences Corporation | 2 | $33 |
| Insulet Corporation | 1 | $27 |
| Bioventus LLC | 1 | $22 |
Products named: VRAYLAR, QULIPTA, ZEPBOUND, UBRELVY, CAPLYTA, MOUNJARO, Cologuard Collection Kit, BOTOX.
Industry payments across CO — which companies pay providers there.
